Development of experimental designs for atherosclerosis studies in mice

被引:76
作者
Daugherty, A [1 ]
Rateri, DL [1 ]
机构
[1] Univ Kentucky, Div Cardiovasc Med, Gill Heart Inst, Lexington, KY 40536 USA
基金
美国国家卫生研究院;
关键词
atherosclerosis; mouse; image analysis;
D O I
10.1016/j.ymeth.2004.11.008
中图分类号
Q5 [生物化学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
The mouse has become the de facto model for the majority of atherosclerosis studies. Studies involving the quantification of lesions in mouse models of the disease represent the basis of our evolving concepts on the biochemical and cellular mechanisms underlying the atherogenic process. Many issues of experimental design, including specific model, strain, gender, atherogenic stimulus, duration of study, group size, and statistical analysis may influence the outcome and interpretation of atherosclerosis studies. The selection of vascular bed in which to quantify atherosclerotic lesion size could also impact the interpretation of results. Early studies quantified atherosclerotic lesion size in either specific regions or all of the aortic sinus. Measurement of atherosclerosis throughout the aortic intimal surface has become a common mode for defining lesion size. It is likely that other vascular regions will be increasingly used. In addition to size, there is an increased emphasis on identifying and quantifying the cellular and chemical composition of atherosclerotic lesions. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:129 / 138
页数:10
相关论文
共 101 条
[1]
Barry-Lane PA, 2001, J CLIN INVEST, V108, P1513, DOI 10.1172/JCI200111927
[2]
Bocan TMA, 1998, CURR PHARM DESIGN, V4, P37
[3]
Role of leukocyte-specific LDL receptors on plasma lipoprotein cholesterol and atherosclerosis in mice [J].
Boisvert, WA ;
Spangenberg, J ;
Curtiss, LK .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (02) :340-347
[4]
TREATMENT OF SEVERE HYPERCHOLESTEROLEMIA IN APOLIPOPROTEIN E-DEFICIENT MICE BY BONE-MARROW TRANSPLANTATION [J].
BOISVERT, WA ;
SPANGENBERG, J ;
CURTISS, LK .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (02) :1118-1124
[5]
Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis [J].
Boring, L ;
Gosling, J ;
Cleary, M ;
Charo, IF .
NATURE, 1998, 394 (6696) :894-897
[6]
Estrogen reduces atherosclerotic lesion development in apolipoprotein E-deficient mice [J].
Bourassa, PAK ;
Milos, PM ;
Gaynor, BJ ;
Breslow, JL ;
Aiello, RJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (19) :10022-10027
[7]
Brousseau ME, 1999, J LIPID RES, V40, P365
[8]
Angiotensin II-accelerated atherosclerosis and aneurysm formation is attenuated in osteopontin-deficient mice [J].
Bruemmer, D ;
Collins, AR ;
Noh, G ;
Wang, W ;
Territo, M ;
Arias-Magallona, S ;
Fishbein, MC ;
Blaschke, F ;
Kintscher, U ;
Graf, K ;
Law, RE ;
Hsueh, WA .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 112 (09) :1318-1331
[9]
Rupture of the atherosclerotic plaque -: Does a good animal model exist? [J].
Cullen, P ;
Baetta, R ;
Bellosta, S ;
Bernini, F ;
Chinetti, G ;
Cignarella, A ;
von Eckardstein, A ;
Exley, A ;
Goddard, M ;
Hofker, M ;
Hurt-Camejo, E ;
Kanters, E ;
Kovanen, P ;
Lorkowski, S ;
McPheat, W ;
Pentikäinen, M ;
Rauterberg, J ;
Ritchie, A ;
Staels, B ;
Weitkamp, B ;
de Winther, M .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2003, 23 (04) :535-542
[10]
CURTISS LK, 1981, J IMMUNOL, V126, P1382